Atlas Trials

A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria

Clinical trial NCT03217591 · COMPLETED

Trial details

NCT number
NCT03217591
Sponsor
Akebia Therapeutics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus With Diabetic Nephropathy
Start date
2017-08-01
Primary completion
2019-08-20
Enrollment
156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.